Cargando…

Immune correlates of Varlilumab treated cancer patients are consistent with CD27 costimulatory activity

Detalles Bibliográficos
Autores principales:	Bullock, Timothy, McClintic, Hillary, Jeong, Se, Smith, Kelly, Olson, Walt, Ramakrishna, Venky, Vitale, Laura, Green, Jennifer, Yellin, Michael, Davis, Thomas, Keler, Tibor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288379/ http://dx.doi.org/10.1186/2051-1426-2-S3-P100

Ejemplares similares

Characterization of the human T cell response to in vitro CD27 costimulation with varlilumab
por: Ramakrishna, Venky, et al.
Publicado: (2015)

FcγR requirements and costimulatory capacity of Urelumab, Utomilumab, and Varlilumab
por: Leitner, Judith, et al.
Publicado: (2023)

The mechanism of anti-tumor immunity induced by varlilumab, a CD27 agonist mAb, is model dependent
por: He, Li-Zhen, et al.
Publicado: (2015)

Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors
por: Sanborn, Rachel E, et al.
Publicado: (2022)

A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors
por: Burris, Howard, et al.
Publicado: (2013)

Production and N-glycan engineering of Varlilumab in Nicotiana benthamiana
por: Nguyen, Kim Dua, et al.
Publicado: (2023)

Experimentos de anatomía y fisiología /
por: McClintic, J. Robert
Publicado: (1975)

Fisiología del cuerpo humano /
por: McClintic, J. Robert
Publicado: (1983)

A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors
por: Ansell, Stephen, et al.
Publicado: (2013)

Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models
por: He, Li-Zhen, et al.
Publicado: (2013)

Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells
por: Ramakrishna, Venky, et al.
Publicado: (2007)

The price of the CD27–CD70 costimulatory axis: you can't have it all
por: Nolte, Martijn A., et al.
Publicado: (2006)

Structural delineation and phase-dependent activation of the costimulatory CD27:CD70 complex
por: Liu, Weifeng, et al.
Publicado: (2021)

Targeting human CD27 with an agonist antibody stimulates T-cell activation and antitumor immunity
por: Thomas, Lawrence J, et al.
Publicado: (2014)

Conditioning treatment with CD27 Ab enhances expansion and antitumor activity of adoptively transferred T cells in mice
por: Wasiuk, Anna, et al.
Publicado: (2021)

A Review of the Role of the Intestinal Microbiota in Age-Related Macular Degeneration
por: Lin, Phoebe, et al.
Publicado: (2021)

Activation of OX40 and CD27 Costimulatory Signalling in Sheep through Recombinant Ovine Ligands
por: Rojas, José Manuel, et al.
Publicado: (2020)

Mechanical Aortic Valve Thrombosis Successfully Treated With Intravenous Thrombolytic Therapy: A Case Report
por: Mandal, Shobha, et al.
Publicado: (2022)

Expression of costimulatory molecules in the bovine corpus luteum
por: Cannon, Matthew J, et al.
Publicado: (2007)

Costimulatory pathways in transplantation
por: Pilat, Nina, et al.
Publicado: (2011)

RIVA – a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial
por: Lim, Sean H., et al.
Publicado: (2018)

CD95 ligand - death factor and costimulatory molecule?
por: Janssen, O, et al.
Publicado: (2003)

Contributions of Costimulatory Molecule CD137 in Endothelial Cells
por: Yuan, Wei, et al.
Publicado: (2021)

Relationships between survival and habitat suitability of semi‐aquatic mammals
por: Barela, Isidro, et al.
Publicado: (2020)

Transcranial and pulsed focused ultrasound that activates brain can accelerate remyelination in a mouse model of multiple sclerosis
por: Olmstead, T. A., et al.
Publicado: (2018)

Neuroimmune semaphorins as costimulatory molecules and beyond
por: Chapoval, Svetlana P.
Publicado: (2018)

Targeting Costimulatory Pathways in Systemic Sclerosis
por: Boleto, Gonçalo, et al.
Publicado: (2018)

Altered expression of costimulatory molecules in dementias
por: Busse, Stefan, et al.
Publicado: (2021)

CD28 costimulatory signal induces protein arginine methylation in T cells
por: Blanchet, Fabien, et al.
Publicado: (2005)

Immunotherapy of melanoma with the immune costimulatory monoclonal antibodies targeting CD137
por: Li, Shi-Yan, et al.
Publicado: (2013)

Coronavirus-induced demyelination occurs in the absence of CD28 costimulatory signals
por: Gonzales, Donna M, et al.
Publicado: (2004)

Designing integrated interventions to improve nutrition and WASH behaviors in Kenya
por: Jacob Arriola, Kimberly R., et al.
Publicado: (2020)

Development of CDX-527: a bispecific antibody combining PD-1 blockade and CD27 costimulation for cancer immunotherapy
por: Vitale, Laura A., et al.
Publicado: (2020)

CD43 is a murine T cell costimulatory receptor that functions independently of CD28
Publicado: (1995)

Targeting Costimulatory Molecules to Improve Antitumor Immunity
por: Capece, Daria, et al.
Publicado: (2012)

γδ T cell costimulatory ligands in antitumor immunity
por: McGraw, Joseph M., et al.
Publicado: (2022)

Heat-stable antigen is a costimulatory molecule for CD4 T cell growth
Publicado: (1992)

CD95 as a negative or positive costimulatory receptor for primary T cell activation
por: Paulsen, M, et al.
Publicado: (2009)

Complexities in comparing the impact of costimulatory domains on approved CD19 CAR functionality
por: Smith, Richard, et al.
Publicado: (2023)

Identification of a costimulatory molecule rapidly induced by CD40L as CD44H
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_v0n2me2mjsk1ig89l2top89rct